Health-care companies ticked up as traders rotated back into the sector from more rate-sensitive areas of the market.

Swiss drug giant Roche Holding rose sharply for the week as its weight-loss drug candidate demonstrated potential in an early-stage trial.


Write to Rob Curran at rob.curran@dowjones.com

(END) Dow Jones Newswires

05-17-24 1750ET